Frontiers in Lipid Management: Nucleotide Acid-based Cholesterol-lowering
City
Webinar
Type of event
virtual
Invitation
Dear Dr.
The Zurich Heart House would like to invite you to a special webinar on
Frontiers in Lipid Management: Nucleotide Acid-based Cholesterol-lowering
Date: Wednesday, November 17th, 2021, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Thomas F. Lüscher, Zürich and London
Christian Müller, Basel
Organized by
Programme
Chairs in ZHH Studio: Thomas F. Lüscher, Zürich and London and Christian Müller, Basel
| 17:00 | Introduction: Do we really need cholesterol? | Thomas F. Lüscher, Zurich/London |
| 17:15 | Lifetime risk: Lessons from Mendelian Randomization Studies | Georg Ehret, Geneva |
| 17:30 | Familial hypercholesterolemia: Detection and Management | David Nanchen, Lausanne |
| 17:45 | Genetic risk scores: Ready for prime time? | Alberico Catapano, Milan |
| 18:00 | Lipid management in Switzerland: Is there a treatment gap? | Konstantinos Koskinas, Berne |
| 18:15 | RNA Interference to treat hyperlipidemia: The Inclisiran programme | John J. Kastelein, Amsterdam |
| 18:30 | Panel discussion | Faculty |
This programme is supported by Novartis.
The scientific programme has not been influenced in any way by its sponsor.
Accreditation
This webinar has been accredited with 2 SGK credits and has been submitted to EACCME for accreditation.